Piramal Pharma Ltd. - PPLPHARMA, 543635 corporate action history

Piramal Pharma Ltd. NSE: PPLPHARMA | BSE: 543635

Mid-range Performer

Download real time

198.70 -2.46 (-1.22%)

35.47% Fall from 52W High

1.1M

NSE+BSE Volume

NSE 04 Sep, 2025 9:28 AM (IST)

Piramal Pharma Ltd. Bonus history

Piramal Pharma Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Piramal Pharma Ltd. Split history

Piramal Pharma Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Piramal Pharma Ltd.

Piramal Pharma Ltd. has declared 2 dividends since July 12, 2024.

In the past 12 months, Piramal Pharma Ltd. has declared an equity dividend amounting to ₹0.14 per share.

At the current share price of ₹198.7000, Piramal Pharma Ltd.'s dividend yield is 0.07%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
16 Jul 2025	0.14	FINAL	16 Jul 2025	Equity Share
12 Jul 2024	0.11	FINAL	12 Jul 2024	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Piramal Pharma Ltd.

The latest board meeting for Piramal Pharma Ltd. took place on 28 Jul 2025, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
28 Jul 2025	Quarterly Results	-
14 May 2025	Audited Results & Final Dividend	-
28 Jan 2025	Quarterly Results	-
23 Oct 2024	Quarterly Results	-
26 Jul 2024	Quarterly Results	-
10 May 2024	Audited Results & Final Dividend	-
30 Jan 2024	Quarterly Results	-
27 Oct 2023	Quarterly Results	-
03 Aug 2023	Quarterly Results	-
24 May 2023	Audited Results	-

See all Board Meetings for Piramal Pharma Ltd.

Rights history for Piramal Pharma Ltd.

Piramal Pharma Ltd. issued rights 1 time since Aug. 2, 2023. Piramal Pharma Ltd. had last issued Rights shares of ₹10.0/- in the ratio of 5.0:46.0 @ premium of ₹71.0/- on Aug. 2, 2023.

Ex-Date	Ratio	Face Value	Premium	Record Date
02 Aug 2023	5.0:46.0	10.0	71.0	02 Aug 2023

See all Rights History for Piramal Pharma Ltd.

VOTE: Is Piramal Pharma Ltd. worth buying?

382 Votes:

Buy 82.72%

Sell 10.99%

Hold 6.28%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >